Pfizer to Acquire Vaccines from GlaxoSmithKline

In The News
June 24, 2015

Ropes & Gray represented Pfizer Inc. in its agreement with GlaxoSmithKline to acquire its quadrivalent meningitis ACWY vaccines, Nimenrix and Mencevax, for a total consideration of approximately $130 million (€115 million).

The transaction, announced June 22, is subject to customary closing conditions as well as regulatory approvals in several markets, and is expected to close in the second half of 2015.

The Ropes & Gray team was led by mergers & acquisitions partner Christopher Comeau.